CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 4 Planned sale Chief Accounting Officer sold 2,347 shares at $6.74 ($15,819)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Executive Officer acquired 350,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 115,000 shares (grant or award)
- 4 Grant or award Chief Legal Officer acquired 150,000 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 50,000 shares (grant or award)
- 10-K Report Annual Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 8-K Event Executive or director change · Other events
- 4 Planned sale Chief Executive Officer sold 19,106 shares at $7.43 ($141,958)
- 4 Planned sale Chief Accounting Officer sold 2,273 shares at $7.43 ($16,888)
- 4 Planned sale Chief Medical Officer sold 6,643 shares at $7.43 ($49,357)
- 4 Planned sale Chief Legal Officer sold 4,519 shares at $7.43 ($33,576)
Page 8 of 26 · 506 filings